Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|July 1, 2006
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancerMads Nikolaj Holten-Andersen, Hans Jørgen Nielsen, Steen Sørensen, et al.
Scandinavian Journal of Gastroenterology|January 29, 2008
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancerNanna Møller Sørensen, Anne Sofie Schrohl, Vibeke Jensen, et al.
Breast Cancer (Tokyo, Japan)|February 29, 2020
Male breast cancer: clinicopathological characterization of a National Danish cohort 1980-2009Anne Marie Bak Jylling, Vibeke Jensen, Giedrius Lelkaitis, et al.
Acta Oncologica (Stockholm, Sweden)|November 17, 2016
Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patientsTinne Laurberg, Jan Alsner, Trine Tramm, et al.
Molecular & Cellular Proteomics : MCP|January 11, 2005
Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patientsSidse Ørnbjerg Würtz, Ib Jarle Christensen, Anne-Sofie Schrohl, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 22, 2013
TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell lineXiaohong Deng, Louise Fogh, Ulrik Lademann, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patientsJan Alsner, Vibeke Jensen, Marianne Kyndi, et al.
Danish Medical Journal|April 8, 2017
The rate of invasive testing for trisomy 21 is reduced after implementation of NIPTLouise Bjerregaard, Anne Betsagoo Stenbakken, Camilla Skov Andersen, et al.
Clinical Chemistry|July 27, 2002
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassayMads N Holten-Andersen, Ib Jarle Christensen, Hans Jørgen Nielsen, et al.
Molecular & Cellular Proteomics : MCP|April 4, 2003
Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancerAnne-Sofie Schrohl, Ib Jarle Christensen, Anders N Pedersen, et al.
Pageof 3